Nucleotide analogues as inhibitors of SARS‐CoV Polymerase

SARS‐CoV‐2, a member of the coronavirus family, has caused a global public health emergency. Based on our analysis of hepatitis C virus and coronavirus replication, and the molecular structures and activities of viral inhibitors, we previously reasoned that the FDA‐approved hepatitis C drug EPCLUSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Jingyue, Li, Xiaoxu, Kumar, Shiv, Jockusch, Steffen, Chien, Minchen, Tao, Chuanjuan, Morozova, Irina, Kalachikov, Sergey, Kirchdoerfer, Robert N., Russo, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596664/
https://www.ncbi.nlm.nih.gov/pubmed/33124786
http://dx.doi.org/10.1002/prp2.674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596664/
https://www.ncbi.nlm.nih.gov/pubmed/33124786
http://dx.doi.org/10.1002/prp2.674

Ejemplares similares